Study evaluates the use of tirzepatide in overweight/obese adults with type 1 diabetes

A new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT) evaluated the use of tirzepatide in overweight/obese adults with type 1 diabetes.

Related Keywords

United States ,Satish Garg ,Mary Ann Liebert Inc ,University Of Colorado Denver ,Diabetes Technology Therapeutics ,Ann Liebert ,Diabetes Technology ,Colorado Denver ,Western Europe ,Diabetes ,Efficacy ,Type 1 Diabetes ,Cardiovascular Disease ,Drug Delivery ,Drugs ,Glucose ,Ba1c ,Insulin ,Research ,Software ,Technology ,Herapeutics ,Type 2 Diabetes ,Weight Loss ,